SAN DIEGO — Patients with nickel allergy and severe refractory symptoms after implantation with an atrial septal closure device experienced complete resolution of symptoms after device explantation, ...

A novel study by Canadian physicians reported that the BioSTAR biodegradable implant achieved comparable closure rates to the Amplatzer Septal Occluder in children with atrial septal defect. A novel ...

Please provide your email address to receive an email when new articles are posted on . W.L. Gore and Associates announced its occluder device was approved by the FDA for percutaneous closure of ...

Initial data looking at safety and efficacy of an interatrial septal occluder with a bioresorbable frame show promise for closing atrial septal defects (ASDs), but the study authors suggest a redesign ...

Atheart Medical Inc. came on the market with splash, simultaneously announcing the company’s formation and its launch of a U.S. investigational device exemption (IDE) trial for the Resept ASD occluder ...

Expert Rev Cardiovasc Ther. 2007;5(6):1135-1146. Diagnosing a secundum ASD is more often than not incidental because the defect normally causes symptoms late in adult life. Echocardiography and MRI ...

The Structural Heart Occlusion Devices market presents opportunities in offering minimally invasive solutions for congenital heart defects, enhancing recovery. Insights on market trends, competitive ...

The growth in the heart closure devices market from 2024-2030 is mainly driven by several factors: the rising incidence of congenital heart defects, increased use of MRI procedures, greater awareness ...